Villain E, Bonnet D, Iserin L, Aggoun Y, Sidi D, Kachaner J
Service de cardiologie pédiatrique, Hôpital Necker/enfants-malades, Paris.
Arch Mal Coeur Vaiss. 1996 Jul;89(7):851-6.
The Mustard and Senning procedures may be complicated by atrial tachyarrhythmias. In order to determine their prognosis, the authors undertook a review of the 288 patients operated and followed up in their department. Thirty-six (12.5%) had documented atrial tachycardias. In 13 cases, Holter monitoring showed bursts of atrial tachycardia. In the other 23 cases, the tachycardia was sustained and often caused severe symptoms (syncope). Reduction of the sustained forms was obtained by rapid atrial pacing, cardioversion or amiodarone therapy. After restoration of sinus rhythm, several therapeutic protocols were used, often in the same patient: abstention, leading to 5 recurrences in 6 cases; treatment with betablockers in 12 patients with well tolerated or exercise-induced atrial tachycardia with 11 successes; amiodarone, with 4 relapses out of 5 when the dosage was less than 200 mg/m2/day and 13 successes out of 18 when the dosage was 200-250 mg/m2/day. During a follow-up of 1 to 19 years, 6 severe complications (neurological sequellae, cardiac failure), and 6 deaths, were observed. All these patients were poorly controlled and continued to be have tachyarrhythmias. The authors conclude that tachyarrhythmias are neither rare nor always symptomatic, so justifying their systematic investigation. They should be reduced by oral amiodarone or rapid atrial pacing depending on the clinical urgency, never by intravenous antiarrhythmics which can be dangerous. The poor prognosis associated with tachyarrhythmias makes their control essential either with betablockers or good doses of amiodarone, eventually covered by permanent cardiac pacing.
马斯塔德手术和森宁手术可能并发房性快速性心律失常。为了确定其预后,作者对在其科室接受手术并随访的288例患者进行了回顾性研究。36例(12.5%)有记录的房性心动过速。13例动态心电图监测显示有房性心动过速发作。另外23例中,心动过速为持续性,且常引起严重症状(晕厥)。通过快速心房起搏、心脏电复律或胺碘酮治疗可减少持续性心律失常。恢复窦性心律后,常对同一患者采用几种治疗方案:不治疗,6例中有5例复发;12例耐受性良好或运动诱发的房性心动过速患者使用β受体阻滞剂治疗,11例成功;使用胺碘酮,剂量小于200mg/m²/天时,5例中有4例复发,剂量为200 - 250mg/m²/天时,18例中有13例成功。在1至19年的随访中,观察到6例严重并发症(神经后遗症、心力衰竭)和6例死亡。所有这些患者控制不佳,仍有心律失常发作。作者得出结论,快速性心律失常既不罕见也不总是有症状,因此有理由进行系统检查。应根据临床紧急情况,通过口服胺碘酮或快速心房起搏来减少心律失常,绝不能使用有危险的静脉抗心律失常药物。与快速性心律失常相关的预后不良使得使用β受体阻滞剂或大剂量胺碘酮进行控制至关重要,最终可通过永久性心脏起搏来解决。